Artiva Biotherapeutics Inc
NASDAQ:ARTV
Artiva Biotherapeutics Inc
NASDAQ:ARTV
Price:
5.32
USD
-3.62%
Market Closed
Market Cap:
$130.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Artiva Biotherapeutics Inc
NASDAQ:ARTV
|
US |
|
Self Storage Group ASA
OSE:SSG
|
NO |
|
Travel + Leisure Co
NYSE:TNL
|
US |
|
H
|
Headway Advanced Materials Inc
TWSE:1776
|
TW |
|
Spectral MD Holdings Ltd
LSE:SMD
|
US |
|
Fulin Plastic Industry (Cayman) Holding Co Ltd
TWSE:1341
|
VN |
|
Wendt (India) Limited
NSE:WENDT
|
IN |
|
G
|
Graft Polymer UK PLC
LSE:GPL
|
UK |
|
S.A.M Trade (Asia) Pte Ltd
OTC:SMFX
|
US |
|
freenet AG
XETRA:FNTN
|
DE |
|
Societe Fonciere Lyonnaise SA
PAR:FLY
|
FR |
|
WeCommerce Holdings Ltd
XTSX:WE
|
CA |
|
R
|
Reliance Infrastructure Ltd
BSE:500390
|
IN |
|
Steel Authority of India Ltd
NSE:SAIL
|
IN |
|
Harapan Duta Pertiwi Tbk PT
IDX:HOPE
|
ID |
|
W
|
Woolworths Holdings Ltd
JSE:WHL
|
ZA |
|
A
|
Atlas Cycles (Haryana) Ltd
NSE:ATLASCYCLE
|
IN |
|
E
|
Elron Ventures Ltd
TASE:ELRN
|
IL |
|
Silicon Motion Technology Corp
NASDAQ:SIMO
|
TW |
|
Azelis Group
LSE:0AA6
|
BE |
|
Starts Proceed Investment Corp
TSE:8979
|
JP |
|
B
|
Bal Pharma Ltd
NSE:BALPHARMA
|
IN |
|
Ulisse Biomed Spa
MIL:UBM
|
IT |
Relative Value
The Relative Value of one
ARTV
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 5.32 USD,
Artiva Biotherapeutics Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ARTV Relative Value
HIDDEN
Multiples Across Competitors
ARTV Competitors Multiples
Artiva Biotherapeutics Inc Competitors
Artiva Biotherapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Artiva Biotherapeutics Inc
NASDAQ:ARTV
|
130.8m USD | 0 | -1.6 | -0.3 | -0.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
